Open Access
| Issue |
BIO Web Conf.
Volume 240, 2026
The 2026 International Conference on Biomedicine, Neuroscience and Biostatistics (ICBNB 2026)
|
|
|---|---|---|
| Article Number | 01012 | |
| Number of page(s) | 3 | |
| Section | Biomedicine, Neuroscience and Biostatistics | |
| DOI | https://doi.org/10.1051/bioconf/202624001012 | |
| Published online | 24 June 2026 | |
- A.J. Hou, L.C. Chen, YY. Chen. Navigating CAR-T cells through the solid-tumour microenvironment. Nat Rev Drug Discov. 20, 531–550 (2021). [Google Scholar]
- J. Lemoine, M. Ruella. Born to survive: how cancer cells resist CAR T cell therapy. J Hematol Oncol. 14, 199 (2021). [Google Scholar]
- C. Feig, JO Jones, M. Kraman, et al. Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer. Proc Natl Acad Sci USA. 110, 20212–20217 (2013). [Google Scholar]
- S. Rafiq, CS. Hackett, RJ. Brentjens. Engineering strategies to overcome the current roadblocks in CAR T cell therapy. Nat Rev Clin Oncol. 17, 147–167 (2020). [Google Scholar]
- KT. Roybal, LJ. Rupp, L. Morsut, et al. Precision tumor recognition by T cells with combinatorial antigen-sensing circuits. Cell. 164, 770–779 (2016). [Google Scholar]
- RC. Lynn, EW. Weber, E. Sotillo, et al. c-Jun overexpression in CAR T cells induces exhaustion resistance. Nature. 576, 293–300 (2019). [Google Scholar]
- K. Hirabayashi, H. Du, Y. Xu, et al. Dual Targeting CAR-T Cells with Optimal Costimulation and Metabolic Fitness enhance Antitumor Activity and Prevent Escape in Solid Tumors. Nat Cancer. 2, 904–918 (2021). [Google Scholar]
- Z. Xiao, L. Todd, L. Huang, et al. Desmoplastic stroma restricts T cell extravasation and mediates immune exclusion and immunosuppression in solid tumors. Nat Commun. 14, 5110 (2023). [Google Scholar]
- N. Jiang, ZY. Yang, HL. Miao, et al. Recent advances in universal chimeric antigen receptor T cell therapy. J Hematol Oncol. 18, 82 (2025). [Google Scholar]
- V. Adhikarla, D. Awuah, E. Caserta, et al. Designing combination therapies for cancer treatment: application of a mathematical framework combining CAR T-cell immunotherapy and targeted radionuclide therapy. Front Immunol. 15, 1358478 (2024). [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.